Imaging Outcomes of a Dopaminergic Neuronal Cell Therapy for Parkinson’s Disease: 18-month Results from a Phase 1 Study of Bemdaneprocel (S30.005)

Evaluate 18F-fluorodopa (18F-DOPA) positron emission tomography (PET) signal 18 months post transplantation (6 months after cessation of immunosuppression) in 12 participants who received intraputamenal transplants of bemdaneprocel.